Skip to content

Clinical trials

Phase 1 Carcinoma, Non-Small-Cell Lung trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1 Country / region: Sweden Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20172
20181
20201
20212
20221
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adaptimmune1
AstraZeneca1
Axelar AB1
BioNTech Cell & Gene Therapies GmbH1
Boehringer Ingelheim1
Genentech, Inc.1
Karolinska University Hospital1
Novartis Pharmaceuticals1
Seagen Inc.1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung10
Stomach Neoplasms3
Colorectal Neoplasms2
Endometrial Neoplasms2
Head and Neck Neoplasms2
Melanoma2
Ovarian Neoplasms2
Testicular Neoplasms2
Uterine Cervical Neoplasms2
Adenocarcinoma of Lung1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.